Delivery Order SPE2DE24DA010-SPE2D625F1UVV
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350 by the Defense Logistics Agency's Medical Supply Chain on August 26, 2025, with an ultimate completion date of August 29, 2025. The contract, which was not set-aside and available through full and open competition, is for the delivery of Aveir Leadless Pacemakers to be performed at Abbott's location in Santa Clara, California. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order with economic price adjustment valued at $10,500 by the Medical Supply Chain, a defense-focused federal agency, on September 12, 2025. The contract, designated as AVEIR (likely referencing Abbott's Aveir Leadless Pacemaker technology), involves delivery to Santa Clara, California, with an ultimate completion date of September 17, 2025. This award was made without a set-aside designation,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350.00 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The contract, which involves no set-aside designation and therefore represents full and open competition, is for the delivery of the Aveir Leadless Pacemaker system to be performed at the contractor's facility in Santa Clara,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order with economic price adjustment totaling $9,500 by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as AVEIR and issued on July 29, 2025, with an ultimate completion date of August 1, 2025, will be performed in Santa Clara, California. This delivery order was awarded without set-aside designation, indicating full and open competition among...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $8,750 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and is not subject to any set-aside designation, indicating full and open competition. The award covers delivery of the AVEIR Leadless Pacemaker to the place...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $14,850 by the Department of Defense's Medical Supply Chain on July 24, 2025, with an ultimate completion date of July 29, 2025. The contract is for the AVEIR product line and will be performed in Santa Clara, California. This delivery order was issued without a set-aside designation, indicating full and open competition. The award represents a task order under Abbott's broader...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Medical Supply Chain division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 4, 2025, represents a delivery order under a larger indefinite delivery vehicle. This award was made through full and open competition with no set-aside designation. The place of performance is Santa Clara, California....
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $9,500 fixed-price delivery order (Contract No. 4569453256) for AVEIR products by the Defense Logistics Agency's Medical Supply Chain on September 12, 2025, with an ultimate completion date of September 17, 2025. The work will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and open competition among qualified vendors. Abbott Vascular has...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain division. The contract, issued on May 20, 2025, with an ultimate completion date of June 9, 2025, represents a child contract under Abbott Laboratories Inc.'s parent entity and will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F1UVVDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350.00 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as AVEIR (a reference to Abbott's Aveir Leadless Pacemaker technology), will be performed in Santa Clara, California, and was awarded without a set-aside designation, indicating full and open competition. This delivery order represents a continuation of Abbott's established role as a critical supplier of advanced cardiovascular medical technologies to federal defense healthcare systems. This award reflects Abbott Vascular Inc.'s strategic positioning within the federal procurement ecosystem for specialized medical devices. The contractor has secured a substantial $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive cardiovascular procedural packages, of which this delivery order is a task call. The fixed-price economic price adjustment structure provides budget certainty while allowing for cost adjustments, typical for specialized medical device procurement where material and manufacturing costs may fluctuate. Abbott's extensive experience delivering sophisticated cardiovascular technologies, including stents, pacemakers, and implantable cardiac monitoring systems, positions it as a reliable partner for federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 8/18/25 |